Cargando…

Exosomal microRNAs as tumor markers in epithelial ovarian cancer

Specific microRNAs (miRNAs) are packaged in exosomes that regulate processes in tumor development and progression. The current study focuses on the influence of exosomal miRNAs in the pathogenesis of epithelial ovarian cancer (EOC). MiRNA profiles were determined in exosomes from plasma of 106 EOC p...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Chi, Stevic, Ines, Müller, Volkmar, Ni, Qingtao, Oliveira‐Ferrer, Leticia, Pantel, Klaus, Schwarzenbach, Heidi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6210043/
https://www.ncbi.nlm.nih.gov/pubmed/30107086
http://dx.doi.org/10.1002/1878-0261.12371
_version_ 1783367027561332736
author Pan, Chi
Stevic, Ines
Müller, Volkmar
Ni, Qingtao
Oliveira‐Ferrer, Leticia
Pantel, Klaus
Schwarzenbach, Heidi
author_facet Pan, Chi
Stevic, Ines
Müller, Volkmar
Ni, Qingtao
Oliveira‐Ferrer, Leticia
Pantel, Klaus
Schwarzenbach, Heidi
author_sort Pan, Chi
collection PubMed
description Specific microRNAs (miRNAs) are packaged in exosomes that regulate processes in tumor development and progression. The current study focuses on the influence of exosomal miRNAs in the pathogenesis of epithelial ovarian cancer (EOC). MiRNA profiles were determined in exosomes from plasma of 106 EOC patients, eight ovarian cystadenoma patients, and 29 healthy women by TaqMan real‐time PCR‐based miRNA array cards containing 48 different miRNAs. In cell culture experiments, the impact of miR‐200b and miR‐320 was determined on proliferation and apoptosis of ovarian cancer cell lines. We report that miR‐21 (P = 0.0001), miR‐100 (P = 0.034), miR‐200b (P = 0.008), and miR‐320 (P = 0.034) are significantly enriched, whereas miR‐16 (P = 0.009), miR‐93 (P = 0.014), miR‐126 (P = 0.012), and miR‐223 (P = 0.029) are underrepresented in exosomes from plasma of EOC patients as compared to those of healthy women. The levels of exosomal miR‐23a (P = 0.009, 0.008) and miR‐92a (P = 009, 0.034) were lower in ovarian cystadenoma patients than in EOC patients and healthy women, respectively. The exosomal levels of miR‐200b correlated with the tumor marker CA125 (P = 0.002) and patient overall survival (P = 0.019). MiR‐200b influenced cell proliferation (P = 0.0001) and apoptosis (P < 0.008). Our findings reveal specific exosomal miRNA patterns in EOC and ovarian cystadenoma patients, which are indicative of a role of these miRNAs in the pathogenesis of EOC.
format Online
Article
Text
id pubmed-6210043
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-62100432018-11-08 Exosomal microRNAs as tumor markers in epithelial ovarian cancer Pan, Chi Stevic, Ines Müller, Volkmar Ni, Qingtao Oliveira‐Ferrer, Leticia Pantel, Klaus Schwarzenbach, Heidi Mol Oncol Research Articles Specific microRNAs (miRNAs) are packaged in exosomes that regulate processes in tumor development and progression. The current study focuses on the influence of exosomal miRNAs in the pathogenesis of epithelial ovarian cancer (EOC). MiRNA profiles were determined in exosomes from plasma of 106 EOC patients, eight ovarian cystadenoma patients, and 29 healthy women by TaqMan real‐time PCR‐based miRNA array cards containing 48 different miRNAs. In cell culture experiments, the impact of miR‐200b and miR‐320 was determined on proliferation and apoptosis of ovarian cancer cell lines. We report that miR‐21 (P = 0.0001), miR‐100 (P = 0.034), miR‐200b (P = 0.008), and miR‐320 (P = 0.034) are significantly enriched, whereas miR‐16 (P = 0.009), miR‐93 (P = 0.014), miR‐126 (P = 0.012), and miR‐223 (P = 0.029) are underrepresented in exosomes from plasma of EOC patients as compared to those of healthy women. The levels of exosomal miR‐23a (P = 0.009, 0.008) and miR‐92a (P = 009, 0.034) were lower in ovarian cystadenoma patients than in EOC patients and healthy women, respectively. The exosomal levels of miR‐200b correlated with the tumor marker CA125 (P = 0.002) and patient overall survival (P = 0.019). MiR‐200b influenced cell proliferation (P = 0.0001) and apoptosis (P < 0.008). Our findings reveal specific exosomal miRNA patterns in EOC and ovarian cystadenoma patients, which are indicative of a role of these miRNAs in the pathogenesis of EOC. John Wiley and Sons Inc. 2018-10-09 2018-11 /pmc/articles/PMC6210043/ /pubmed/30107086 http://dx.doi.org/10.1002/1878-0261.12371 Text en © 2018 The Authors. Published by FEBS Press and John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Pan, Chi
Stevic, Ines
Müller, Volkmar
Ni, Qingtao
Oliveira‐Ferrer, Leticia
Pantel, Klaus
Schwarzenbach, Heidi
Exosomal microRNAs as tumor markers in epithelial ovarian cancer
title Exosomal microRNAs as tumor markers in epithelial ovarian cancer
title_full Exosomal microRNAs as tumor markers in epithelial ovarian cancer
title_fullStr Exosomal microRNAs as tumor markers in epithelial ovarian cancer
title_full_unstemmed Exosomal microRNAs as tumor markers in epithelial ovarian cancer
title_short Exosomal microRNAs as tumor markers in epithelial ovarian cancer
title_sort exosomal micrornas as tumor markers in epithelial ovarian cancer
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6210043/
https://www.ncbi.nlm.nih.gov/pubmed/30107086
http://dx.doi.org/10.1002/1878-0261.12371
work_keys_str_mv AT panchi exosomalmicrornasastumormarkersinepithelialovariancancer
AT stevicines exosomalmicrornasastumormarkersinepithelialovariancancer
AT mullervolkmar exosomalmicrornasastumormarkersinepithelialovariancancer
AT niqingtao exosomalmicrornasastumormarkersinepithelialovariancancer
AT oliveiraferrerleticia exosomalmicrornasastumormarkersinepithelialovariancancer
AT pantelklaus exosomalmicrornasastumormarkersinepithelialovariancancer
AT schwarzenbachheidi exosomalmicrornasastumormarkersinepithelialovariancancer